Budget genome

By Richard Grant Budget genome Courtesy of Jay Shendure The paper S.B. Ng et al., “Exome sequencing identifies the cause of a Mendelian disorder,” Nat Genet, 42:30–35, 2009. (ID: 1600956) The finding: Tracking down the genetic cause of inherited diseases is time consuming and expensive. But Jay Shendure of the University of Washington’s Department of Genome Sciences found a way to make it a whole lot easier. Instead of

Written byRichard Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper

S.B. Ng et al., “Exome sequencing identifies the cause of a Mendelian disorder,” Nat Genet, 42:30–35, 2009. (ID: 1600956)

The finding:

Tracking down the genetic cause of inherited diseases is time consuming and expensive. But Jay Shendure of the University of Washington’s Department of Genome Sciences found a way to make it a whole lot easier. Instead of looking for problem genes by sequencing the full genome, Shendure’s lab sequenced only the exome—the protein-coding regions of the genome, including the exon boundaries—of patients. In the process, he found the gene that causes Miller syndrome.

The approach:

Sequencing and analyzing the exome makes economic sense: it’s only 1% of the full genome. With the right software tools—and just a little bit of luck—you only need to study a small number of individuals. Shendure’s lab had shown that the idea worked last year when it verified the gene responsible for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies